课题基金 / 基金详情

Charge sensitive optical detection for high-throughput study of small molecules

Charge sensitive optical detection for high-throughput study of small molecules
用于小分子高通量研究的电荷敏感光学检测
批准号:
9147498
负责人:
NONGJIAN TAO
金额:
$38.14万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-08-01 至 2019-07-31

项目摘要

项目成果

NONGJIAN TAO的其他基金

相似基金

相关文献

中文摘要
翻译
项目总结 一种可以检测和量化小分子结合和生化反应动力学的技术, 例如翻译后蛋白质修饰,对于理解癌症的机制是至关重要的 启动和进展,用于发现癌症生物标记物,并用于筛选抗癌药物候选。 目前,使用最广泛的技术是使用荧光标记,这对于具有 与荧光染料相当的大小,特别是在定量动力学信息方面。各种无标签 技术已经开发出来,但它们的灵敏度随着分子质量的增加而降低,使其变得非常 对检测小分子和涉及微小质量变化的生化反应具有挑战性。致信地址 在这种需求下,本项目将开发一种电荷敏感光学检测(CSOD)技术。CSODIS 与标准微板技术兼容,使其对高通量筛选和 分子相互作用和反应的分析。基本原则是在一个 用于癌症研究的创新分子分析技术(IMAT)R21基金。在目前的R33项目中, 该团队将与学术研究实验室和制药公司的合作者密切合作,并 生物分析仪器公司为未得到满足的需求开发和验证技术。 该项目的成功将导致一种新的无标签高通量筛选技术 测量分子相互作用,特别是小分子相互作用和翻译后修饰。 这些过程对癌症的研究、诊断和治疗非常重要。
英文摘要
PROJECT SUMMARY A technology that can detect and quantify the kinetics of small molecule binding and biochemical reactions, such as post-translational protein modifications, is critical for understanding the mechanisms underlying cancer initiation and progression, for discovering cancer biomarkers, and for screening cancer drug candidates. Currently, the most widely used technology uses fluorescence labels, which is difficult for small molecules with sizes comparable to the fluorescent dyes, especially for quantitative kinetic information. Various label-free techniques have been developed, but their sensitivity diminishes with the molecular mass, making it extremely challenging to detect small molecules and biochemical reactions that involve small mass changes. To address this need, a charge sensitive optical detection (CSOD) technology will be developed in this project. CSOD is compatible with the standard microplate technology, making it attractive for high-throughput screening and analysis of molecular interactions and reactions. The basic principle was established with the support of an IMAT (Innovative Molecular Analysis Technologies for cancer research) R21 grant. In the present R33 project, the team will work closely with collaborators in academic research labs and pharmaceutical companies, and a bioanalytical instrument company to develop and validate the technology for the unmet need. The success of the project will lead to a new label-free high-throughput screening technology for measuring molecular interactions, particularly small molecule interactions and post-translational modifications. These processes are highly important for the research, diagnosis and treatment of cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Measuring small molecule interactions with membrane proteins on single cells via detecting nanometer scale membrane deformations
Charge sensitive optical detection for high-throughput study of small molecules
A personal exposure and response monitoring system for pediatric asthma study
Plasmonic mapping of ion channel activities in single cells
海外基金